Compare DK & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DK | NNNN |
|---|---|---|
| Founded | 2001 | 2021 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Integrated oil Companies | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.5B |
| IPO Year | 2017 | N/A |
| Metric | DK | NNNN |
|---|---|---|
| Price | $45.18 | $25.67 |
| Analyst Decision | Hold | |
| Analyst Count | 17 | 0 |
| Target Price | ★ $36.94 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 20.3K |
| Earning Date | 05-06-2026 | 04-28-2026 |
| Dividend Yield | ★ 2.27% | N/A |
| EPS Growth | ★ 95.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $0.50 | N/A |
| Revenue Next Year | $0.58 | N/A |
| P/E Ratio | ★ N/A | $446.57 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.07 | $5.91 |
| 52 Week High | $48.32 | $55.65 |
| Indicator | DK | NNNN |
|---|---|---|
| Relative Strength Index (RSI) | 58.55 | 56.03 |
| Support Level | $36.00 | $19.53 |
| Resistance Level | $48.32 | $30.70 |
| Average True Range (ATR) | 2.51 | 2.11 |
| MACD | -0.31 | 0.52 |
| Stochastic Oscillator | 54.19 | 71.53 |
Delek US Holdings Inc is an integrated energy business focused on petroleum refining, transportation and storage; wholesale crude oil, intermediate, and refined products, and convenience stores retailing. The company owns and operates independent refineries that produce a variety of petroleum products for transportation and industrial markets in the United States. It has two segments: Refining segment and Logistics segment. The logistics segment generates revenue through gathering, transporting, and storing crude oil and intermediate products, as well as by marketing, storing, and distributing refined products. The company also offers a collection of retail fuel and convenience stores operating in the Southeast region of the United States.
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.